Updated 2025-2026 formulations of mRNA-1283 and BNT162b2 protect older adults against severe COVID-19 outcomes and medically attended illness.

Postacute COVID-19 symptom diagnoses, health care spending, and utilization among Medicare beneficiaries diminish within 3 ...

Infectious disease outbreaks, such as measles, HIV, and mpox, expose critical vulnerabilities across public health systems.

The CDC is warning individuals against eating shredded iceberg lettuce served at Taco Bell locations across 5 states due to a Cyclospora outbreak.

While elevated day 7 procalcitonin indicates greater mortality risk in bacteremia, prolonged antibiotic treatment does not improve survival.

Influenza vaccination significantly reduces the risk of influenza-associated mortality in pediatric patients with or without underlying conditions.

Clinicians should maintain a high index of suspicion for Cyclospora in patients with prolonged or relapsing watery diarrhea this summer.

A study of insured US patients shows that oseltamivir is the primary influenza antiviral, while inpatient use of peramivir continues to grow.

The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.

Adults aged 18 to 64 years with high-risk conditions demonstrate higher rates of RSV-related LRTD than those without these conditions.

Millions across the Midwest and Northeast are breathing dangerous air as heavy smoke from wildfires in Canada and Minnesota spreads.

A meta-analysis indicates HD-IIV is superior to SD-IIV for reducing hospitalizations in adults aged 65 years and older.